AJP - GI AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 264: G886-G894, 1993;
0193-1857/93 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rangachari, P. K.
Right arrow Articles by Betti, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rangachari, P. K.
Right arrow Articles by Betti, P. A.

AJP - Gastrointestinal and Liver Physiology, Vol 264, Issue 5 886-G894, Copyright © 1993 by American Physiological Society


ARTICLES

Biological activity of metabolites of PGD2 on canine proximal colon

P. K. Rangachari and P. A. Betti
Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

The responses of the canine colonic epithelium to the metabolites of prostaglandin D2 (PGD2) were compared with those elicited by the parent prostanoid. Dose-response relations to PGD2 showed three distinct patterns: 1) a dose-dependent decrease in short-circuit current (Isc) at lower concentrations followed by a dose-dependent increase at higher concentrations; 2) dose-dependent decreases, with no increase even at the highest concentrations tested; and 3) dose-dependent increases in Isc, with no decreases at any concentration. The colon responded differently to the two enzymatically derived metabolites 13,14-dihydro-15-keto-PGD2 (DK) and 11 beta-PGF2 alpha. The former consistently produced only dose-dependent decreases in Isc, while the latter elicited only dose-dependent increases. Pretreatment of tissues with 11 beta-PGF2 alpha altered the responses to PGD2 such that only decreases were noted. Conversely, pretreatment with DK caused PGD2 to elicit only increases in Isc. The nonenzymatically derived PGJ2 elicited responses comparable to those seen with PGD2. Pretreatment of tissues with indomethacin abolished responses to 11 beta-PGF2 alpha as well as its isomer, PGF2 alpha, suggesting the involvement of a cyclooxygenase product. Responses to PGE2 were, however, amplified. Cross-desensitization was noted between the two isomers. Tissues desensitized to either 11 beta-PGF2 alpha or PGF2 alpha were responsive to DK as well as PGE2; however, tissues desensitized to PGE2 were unresponsive to 11 beta-PGF2 alpha. Thus the canine colonic epithelium responds not only to PGD2 but also to its derived metabolites. Variability in the response to PGD2 between animals could stem from differences at the receptor level and/or differential production of these metabolites.


This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. R. Halm and S. T. Halm
Prostanoids stimulate K secretion and Cl secretion in guinea pig distal colon via distinct pathways
Am J Physiol Gastrointest Liver Physiol, October 1, 2001; 281(4): G984 - G996.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
X. Hou, L. J. Roberts II, D. F. Taber, J. D. Morrow, K. Kanai, F. Gobeil Jr., M. H. Beauchamp, S. G. Bernier, G. Lepage, D. R. Varma, et al.
2,3-Dinor-5,6-dihydro-15-F2t-isoprostane: a bioactive prostanoid metabolite
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R391 - R400.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
H. Hirai, K. Tanaka, O. Yoshie, K. Ogawa, K. Kenmotsu, Y. Takamori, M. Ichimasa, K. Sugamura, M. Nakamura, S. Takano, et al.
Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor CRTH2
J. Exp. Med., January 16, 2001; 193(2): 255 - 262.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. L. Elmhurst, P.-A. Betti, and P. K. Rangachari
Intestinal Effects of Isoprostanes: Evidence for the Involvement of Prostanoid EP and TP Receptors
J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1198 - 1205.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online